These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 30550800)

  • 21. Development of treatment strategies to combat Ebola and Marburg viruses.
    Paragas J; Geisbert TW
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):67-76. PubMed ID: 16441210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In silico derived small molecules bind the filovirus VP35 protein and inhibit its polymerase cofactor activity.
    Brown CS; Lee MS; Leung DW; Wang T; Xu W; Luthra P; Anantpadma M; Shabman RS; Melito LM; MacMillan KS; Borek DM; Otwinowski Z; Ramanan P; Stubbs AJ; Peterson DS; Binning JM; Tonelli M; Olson MA; Davey RA; Ready JM; Basler CF; Amarasinghe GK
    J Mol Biol; 2014 May; 426(10):2045-58. PubMed ID: 24495995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Host and Viral Proteins Modulating Ebola and Marburg Virus Egress.
    Gordon TB; Hayward JA; Marsh GA; Baker ML; Tachedjian G
    Viruses; 2019 Jan; 11(1):. PubMed ID: 30609802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers.
    Warfield KL; Swenson DL; Olinger GG; Nichols DK; Pratt WD; Blouch R; Stein DA; Aman MJ; Iversen PL; Bavari S
    PLoS Pathog; 2006 Jan; 2(1):e1. PubMed ID: 16415982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rescue of Ebola virus from cDNA using heterologous support proteins.
    Theriault S; Groseth A; Neumann G; Kawaoka Y; Feldmann H
    Virus Res; 2004 Nov; 106(1):43-50. PubMed ID: 15522446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Sensitive in Vitro High-Throughput Screen To Identify Pan-filoviral Replication Inhibitors Targeting the VP35-NP Interface.
    Liu G; Nash PJ; Johnson B; Pietzsch C; Ilagan MX; Bukreyev A; Basler CF; Bowlin TL; Moir DT; Leung DW; Amarasinghe GK
    ACS Infect Dis; 2017 Mar; 3(3):190-198. PubMed ID: 28152588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamic Phosphorylation of VP30 Is Essential for Ebola Virus Life Cycle.
    Biedenkopf N; Lier C; Becker S
    J Virol; 2016 May; 90(10):4914-4925. PubMed ID: 26937028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No exit: targeting the budding process to inhibit filovirus replication.
    Harty RN
    Antiviral Res; 2009 Mar; 81(3):189-97. PubMed ID: 19114059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for Viral mRNA Export from Ebola Virus Inclusion Bodies by the Nuclear RNA Export Factor NXF1.
    Wendt L; Brandt J; Ushakov DS; Bodmer BS; Pickin MJ; Groseth A; Hoenen T
    J Virol; 2022 Sep; 96(18):e0090022. PubMed ID: 36040180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polyamines and Hypusination Are Required for Ebolavirus Gene Expression and Replication.
    Olsen ME; Filone CM; Rozelle D; Mire CE; Agans KN; Hensley L; Connor JH
    mBio; 2016 Jul; 7(4):. PubMed ID: 27460797
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elucidation of the Cellular Interactome of Ebola Virus Nucleoprotein and Identification of Therapeutic Targets.
    García-Dorival I; Wu W; Armstrong SD; Barr JN; Carroll MW; Hewson R; Hiscox JA
    J Proteome Res; 2016 Dec; 15(12):4290-4303. PubMed ID: 27786485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Innate immune evasion by filoviruses.
    Basler CF
    Virology; 2015 May; 479-480():122-30. PubMed ID: 25843618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Host factor SMYD3 is recruited by Ebola virus nucleoprotein to facilitate viral mRNA transcription.
    Chen J; He Z; Yuan Y; Huang F; Luo B; Zhang J; Pan T; Zhang H; Zhang J
    Emerg Microbes Infect; 2019; 8(1):1347-1360. PubMed ID: 31516086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Filovirus Interferon Antagonists on Responses of Human Monocyte-Derived Dendritic Cells to RNA Virus Infection.
    Yen BC; Basler CF
    J Virol; 2016 May; 90(10):5108-5118. PubMed ID: 26962215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retro-2 and its dihydroquinazolinone derivatives inhibit filovirus infection.
    Shtanko O; Sakurai Y; Reyes AN; Noël R; Cintrat JC; Gillet D; Barbier J; Davey RA
    Antiviral Res; 2018 Jan; 149():154-163. PubMed ID: 29175127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ebola virus VP30 and nucleoprotein interactions modulate viral RNA synthesis.
    Xu W; Luthra P; Wu C; Batra J; Leung DW; Basler CF; Amarasinghe GK
    Nat Commun; 2017 Jun; 8():15576. PubMed ID: 28593988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blockage of filoviral glycoprotein processing by use of a protein-based inhibitor.
    Ströher U; Willihnganz L; Jean F; Feldmann H
    J Infect Dis; 2007 Nov; 196 Suppl 2():S271-5. PubMed ID: 17940960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of Marburg Virus RNA Synthesis by a Synthetic Anti-VP35 Antibody.
    Amatya P; Wagner N; Chen G; Luthra P; Shi L; Borek D; Pavlenco A; Rohrs H; Basler CF; Sidhu SS; Gross ML; Leung DW
    ACS Infect Dis; 2019 Aug; 5(8):1385-1396. PubMed ID: 31120240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of antigen-presenting cells in filoviral hemorrhagic fever: gaps in current knowledge.
    Martinez O; Leung LW; Basler CF
    Antiviral Res; 2012 Mar; 93(3):416-28. PubMed ID: 22333482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-throughput, luciferase-based reverse genetics systems for identifying inhibitors of Marburg and Ebola viruses.
    Uebelhoer LS; Albariño CG; McMullan LK; Chakrabarti AK; Vincent JP; Nichol ST; Towner JS
    Antiviral Res; 2014 Jun; 106():86-94. PubMed ID: 24713118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.